banner ad
Experts Logo
Articles Pen

OBSTETRICS - GYNECOLOGY (OBGYN) ARTICLES MAIN PAGE

Featured articles related to OBGYN Obstetrics and Gynecology, written by expert witnesses and consultants. Contact Us if you are interested in having your work published on our website and linked to your Profile(s).

Featured Articles

Search articles by title, description, author etc.
Sort Non-Featured Profiles
Rabbie-Hanna-Gynecologic-Ocology-Expert.jpg

2/11/2016· Obstetrics - Gynecology (OBGYN)

Histological Grade Predicts for Recurrence in Patients with Uterine Endometrioid Carcinoma without Myometrial Involvement

By: Dr. Rabbie Hanna

Abstract Aim: To evaluate clinical outcomes and identify factors predictive for recurrence in patients with 1988 (FIGO) stage IA uterine endometrioid carcinoma. Patients and Methods: Patients who underwent hysterectomy for stage IA carcinoma were identified in our database. Fisher's exact and ?2 tests were used to identify factors that influenced outcome. Survival plots were generated according to Kaplan-Meier product-limit method and the log-rank test was used to determine significance. Results: A total of 121 patients were identified.

Rabbie-Hanna-Gynecologic-Ocology-Expert.jpg

1/11/2016· Obstetrics - Gynecology (OBGYN)

Adjuvant Therapy of Uterine Clear Cell Carcinoma: A Review

By: Dr. Rabbie Hanna

Purpose Uterine clear-cell carcinoma (UCCC) is a rare subset of type II endometrial carcinoma with a poor prognosis relative to the most common type of endometrioid carcinoma. Due to its rarity, there has been limited direct evidence of the efficacy of specific adjuvant therapy posthysterectomy in women with UCCC. We present a review of current literature regarding adjuvant therapy of uterine clear cell carcinoma.

Rabbie-Hanna-Gynecologic-Ocology-Expert.jpg

1/6/2016· Obstetrics - Gynecology (OBGYN)

Perioperative Outcomes of Robotically Assisted Hysterectomy for Benign Cases With Complex Pathology

By: Dr. Rabbie Hanna

OBJECTIVE: To report on the perioperative outcomes after robotically assisted total hysterectomy for benign indications in a large patient population with predominantly complex pathology.

Featured resources

Experts.com-No broker Movie Ad
Unicourt Logo Button

Follow us

linkedin logo youtube logo rss feed logo